TerrAscend (OTCMKTS:TSNDF – Get Free Report) is one of 43 publicly-traded companies in the “Agricultural production – crops” industry, but how does it contrast to its competitors? We will compare TerrAscend to related companies based on the strength of its analyst recommendations, valuation, risk, profitability, dividends, institutional ownership and earnings.
Analyst Recommendations
This is a breakdown of recent ratings and recommmendations for TerrAscend and its competitors, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
TerrAscend | 0 | 1 | 0 | 1 | 3.00 |
TerrAscend Competitors | 315 | 258 | 604 | 34 | 2.29 |
As a group, “Agricultural production – crops” companies have a potential upside of 54.91%. Given TerrAscend’s competitors higher possible upside, analysts clearly believe TerrAscend has less favorable growth aspects than its competitors.
Profitability
Net Margins | Return on Equity | Return on Assets | |
TerrAscend | -23.95% | -31.48% | -11.40% |
TerrAscend Competitors | -98.15% | -2,439.03% | -14.56% |
Insider & Institutional Ownership
5.8% of TerrAscend shares are owned by institutional investors. Comparatively, 20.7% of shares of all “Agricultural production – crops” companies are owned by institutional investors. 31.9% of TerrAscend shares are owned by insiders. Comparatively, 16.0% of shares of all “Agricultural production – crops” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Volatility & Risk
TerrAscend has a beta of 1.64, suggesting that its stock price is 64% more volatile than the S&P 500. Comparatively, TerrAscend’s competitors have a beta of -19.60, suggesting that their average stock price is 2,060% less volatile than the S&P 500.
Earnings and Valuation
This table compares TerrAscend and its competitors top-line revenue, earnings per share and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
TerrAscend | $317.33 million | -$95.54 million | -1.60 |
TerrAscend Competitors | $1.22 billion | -$827,419.35 | 6.85 |
TerrAscend’s competitors have higher revenue and earnings than TerrAscend. TerrAscend is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Summary
TerrAscend beats its competitors on 7 of the 13 factors compared.
About TerrAscend
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.
Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.